サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：乳房再建の世界市場 (製品別：乳房インプラント、組織拡張器、無細胞性皮膚基質、その他) - 産業分析、市場規模・シェア・成長・動向・予測 (2021年～2031年)
市場調査レポート
商品コード
1110490

乳房再建の世界市場 (製品別：乳房インプラント、組織拡張器、無細胞性皮膚基質、その他) - 産業分析、市場規模・シェア・成長・動向・予測 (2021年～2031年)

Breast Reconstruction Market (Product: Breast Implants, Tissue Expanders, Acellular Dermal Matrix, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 164 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
乳房再建の世界市場 (製品別：乳房インプラント、組織拡張器、無細胞性皮膚基質、その他) - 産業分析、市場規模・シェア・成長・動向・予測 (2021年～2031年)
出版日: 2022年06月02日
発行: Transparency Market Research
ページ情報: 英文 164 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の乳房再建の市場について分析し、過去・現在の成長動向と市場機会、今後の市場指標と考察 (2022年～2031年)、市場収益の動向 (2017年～2031年)、世界市場のCAGRの見通し (2022年～2031年) などを調査しております。

目次

第1章 序文

第2章 前提と調査手法

第3章 エグゼクティブサマリー：世界の乳房再建市場

第4章 市場概要

  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第5章 主な洞察

  • 新製品の発売と規制当局の承認
  • 技術進歩
  • 新型コロナウイルス感染症 (COVID-19) 感染拡大の影響

第6章 世界の乳房再建市場：製品別の分析と予測

  • イントロダクションと定義
  • 主な調査結果/動向
  • 市場規模の予測：製品別 (金額ベース、2017年～2031年)
    • 乳房インプラント
    • 組織拡張器
    • 無細胞性皮膚基質 (ADM)
    • その他
  • 製品別の市場魅力分析

第7章 世界の乳房再建市場：エンドユーザー別の分析と予測

  • イントロダクションと定義
  • 主な調査結果/動向
  • 市場規模の予測：エンドユーザー別 (金額ベース、2017年～2031年)
    • 病院
    • 美容クリニック
    • 外来手術センター
  • エンドユーザー別の市場魅力分析

第8章 世界の乳房再建市場：地域別の分析と予測

  • 主な調査結果
  • 市場規模の予測：地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 地域別の市場魅力分析

第9章 北米乳房再建市場の分析と予測

  • イントロダクション
  • 市場規模の予測：製品別 (金額ベース、2017年～2031年)
  • 市場規模の予測：エンドユーザー別 (金額ベース、2017年～2031年)
  • 市場規模の予測：国別 (金額ベース、2017年～2031年)
    • 米国
    • カナダ
  • 市場魅力分析

第10章 欧州の乳房再建市場の分析と予測

第11章 アジア太平洋の乳房再建市場の分析と予測

第12章 ラテンアメリカの乳房再建市場の分析と予測

第13章 中東・アフリカの乳房再建市場の分析と予測

第14章 競合情勢

  • 市場参入企業：競合マトリックス (階層別・企業規模別)
  • 市場シェア分析/ランキング：企業別 (2021年)
  • 企業プロファイル
    • AbbVie, Inc.
    • Establishment Labs Holdings, Inc.
    • GC Aesthetics
    • Groupe SEBBIN SAS
    • Guangzhou Wanhe Plastic Materials Co., Ltd.
    • Integra LifeSciences
    • Mentor Worldwide LLC (Johnson &Johnson)
    • POLYTECH Health &Aesthetics GmbH
    • RTI Surgical, Inc.
    • Sientra, Inc.
    • その他の著名な企業
図表

List of Tables

  • Table 01: New Product Launches and Regulatory Approvals in Breast Reconstruction Market, by Company
  • Table 02: New Product Launches and Regulatory Approvals in Breast Reconstruction Market, by Company
  • Table 03: Global Breast Reconstruction Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 04: Global Breast Reconstruction Market Value (US$ Mn) Forecast, by Breast Implants, 2017-2031
  • Table 05: Global Breast Reconstruction Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 06: Global Breast Reconstruction Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 07: North America Breast Reconstruction Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 08: North America Breast Reconstruction Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 09: North America Breast Reconstruction Market Size (US$ Mn) Forecast, by Breast Implants, 2017-2031
  • Table 10: North America Breast Reconstruction Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 11: Europe Breast Reconstruction Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe Breast Reconstruction Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 13: Europe Breast Reconstruction Market Size (US$ Mn) Forecast, by Breast Implants, 2017-2031
  • Table 14: Europe Breast Reconstruction Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 15: Asia Pacific Breast Reconstruction Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 16: Asia Pacific Breast Reconstruction Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 17: Asia Pacific Breast Reconstruction Market Size (US$ Mn) Forecast, by Breast Implants, 2017-2031
  • Table 18: Asia Pacific Breast Reconstruction Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 19: Latin America Breast Reconstruction Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 20: Latin America Breast Reconstruction Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 21: Latin America Breast Reconstruction Market Size (US$ Mn) Forecast, by Breast Implants, 2017-2031
  • Table 22: Latin America Breast Reconstruction Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 23: Middle East & Africa Breast Reconstruction Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 24: Middle East & Africa Breast Reconstruction Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 25: Middle East & Africa Breast Reconstruction Market Size (US$ Mn) Forecast, by Breast Implants, 2017-2031
  • Table 26: Middle East & Africa Breast Reconstruction Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Breast Reconstruction Market Size (US$ Mn) and Distribution (%), by Region, 2021 and 2031
  • Figure 02: Global Breast Reconstruction Market Value Share, by Product, 2021
  • Figure 03: Global Breast Reconstruction Market Value Share, by End-user, 2021
  • Figure 04: Global Breast Reconstruction Market Value Share, by Region, 2021
  • Figure 05: Global Breast Reconstruction Market, By Region (US$ Mn), 2021
  • Figure 06: Global Breast Reconstruction Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 07: Global Breast Reconstruction Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 08: Global Breast Reconstruction Market Revenue (US$ Mn), by Breast Implants, 2017-2031
  • Figure 09: Global Breast Reconstruction Market Revenue (US$ Mn), by Tissue Expanders, 2017-2031
  • Figure 10: Global Breast Reconstruction Market Revenue (US$ Mn), by Acellular Dermal Matrix (ADM), 2017-2031
  • Figure 11: Global Breast Reconstruction Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 12: Global Breast Reconstruction Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 13: Global Breast Reconstruction Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 14: Global Breast Reconstruction Market Revenue (US$ Mn), by Hospitals, 2017-2031
  • Figure 15: Global Breast Reconstruction Market Revenue (US$ Mn), by Cosmetology Clinics, 2017-2031
  • Figure 16: Global Breast Reconstruction Market Revenue (US$ Mn), by Ambulatory Surgery Centers, 2017-2031
  • Figure 17: Global Breast Reconstruction Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 18: Global Breast Reconstruction Market Value Share Analysis, by Region, 2021 and 2031
  • Figure 19: Global Breast Reconstruction Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 20: North America Breast Reconstruction Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 21: North America Breast Reconstruction Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 22: North America Breast Reconstruction Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 23: North America Breast Reconstruction Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 24: North America Breast Reconstruction Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 25 North America Breast Reconstruction Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 26: North America Breast Reconstruction Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 27: Europe Breast Reconstruction Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 28: Europe Breast Reconstruction Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 29: Europe Breast Reconstruction Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 30: Europe Breast Reconstruction Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 31: Europe Breast Reconstruction Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 32: Europe Breast Reconstruction Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 33: Europe Breast Reconstruction Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 34: Asia Pacific Breast Reconstruction Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 35: Asia Pacific Breast Reconstruction Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 36: Asia Pacific Breast Reconstruction Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 37: Asia Pacific Breast Reconstruction Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 38: Asia Pacific Breast Reconstruction Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 39: Asia Pacific Breast Reconstruction Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 40: Asia Pacific Breast Reconstruction Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 41: Latin America Breast Reconstruction Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 42: Latin America Breast Reconstruction Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 43: Latin America Breast Reconstruction Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 44: Latin America Breast Reconstruction Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 45: Latin America Breast Reconstruction Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 46: Latin America Breast Reconstruction Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 47: Latin America Breast Reconstruction Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 48: Middle East & Africa Breast Reconstruction Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 49: Middle East & Africa Breast Reconstruction Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 50: Middle East & Africa Breast Reconstruction Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 51: Middle East & Africa Breast Reconstruction Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 52: Middle East & Africa Breast Reconstruction Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 53: Middle East & Africa Breast Reconstruction Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 54: Middle East & Africa Breast Reconstruction Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 55: Market Share Analysis/Ranking, by Company, 2021
目次
Product Code: TMRGL57762

The report provides revenue of the global breast reconstruction market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global breast reconstruction market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the breast reconstruction market.

The report delves into the competitive landscape of the global breast reconstruction market. Key players operating in the global breast reconstruction market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global breast reconstruction market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Breast Reconstruction Market

4. Market Overview

  • 4.1. Overview
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities

5. Key Insights

  • 5.1. New Product Launches and Regulatory Approvals
  • 5.2. Technological Advancements
  • 5.3. COVID-19 Pandemic Impact

6. Global Breast Reconstruction Market Analysis and Forecast, By Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. Breast Implants
      • 6.3.1.1. Silicone
      • 6.3.1.2. Saline
    • 6.3.2. Tissue Expanders
    • 6.3.3. Acellular Dermal Matrix (ADM)
    • 6.3.4. Others
  • 6.4. Market Attractiveness Analysis, By Product

7. Global Breast Reconstruction Market Analysis and Forecast, By End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by End-user, 2017-2031
    • 7.3.1. Hospitals
    • 7.3.2. Cosmetology Clinics
    • 7.3.3. Ambulatory Surgery Centers
  • 7.4. Market Attractiveness Analysis, By End-user

8. Global Breast Reconstruction Market Analysis and Forecast, By Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, By Region

9. North America Breast Reconstruction Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Product, 2017-2031
    • 9.2.1. Breast Implants
      • 9.2.1.1. Silicone
      • 9.2.1.2. Saline
    • 9.2.2. Tissue Expanders
    • 9.2.3. Acellular Dermal Matrix (ADM)
    • 9.2.4. Others
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Hospitals
    • 9.3.2. Cosmetology Clinics
    • 9.3.3. Ambulatory Surgery Centers
  • 9.4. Market Value Forecast, by Country, 2017-2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Product
    • 9.5.2. By End-user
    • 9.5.3. By Country

10. Europe Breast Reconstruction Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product, 2017-2031
    • 10.2.1. Breast Implants
      • 10.2.1.1. Silicone
      • 10.2.1.2. Saline
    • 10.2.2. Tissue Expanders
    • 10.2.3. Acellular Dermal Matrix (ADM)
    • 10.2.4. Others
  • 10.3. Market Value Forecast, by End-user, 2017-2031
    • 10.3.1. Hospitals
    • 10.3.2. Cosmetology Clinics
    • 10.3.3. Ambulatory Surgery Centers
  • 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Italy
    • 10.4.5. Spain
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Product
    • 10.5.2. By End-user
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Breast Reconstruction Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2017-2031
    • 11.2.1. Breast Implants
      • 11.2.1.1. Silicone
      • 11.2.1.2. Saline
    • 11.2.2. Tissue Expanders
    • 11.2.3. Acellular Dermal Matrix (ADM)
    • 11.2.4. Others
  • 11.3. Market Value Forecast, by End-user, 2017-2031
    • 11.3.1. Hospitals
    • 11.3.2. Cosmetology Clinics
    • 11.3.3. Ambulatory Surgery Centers
  • 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.4.1. Japan
    • 11.4.2. China
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Product
    • 11.5.2. By End-user
    • 11.5.3. By Country/Sub-region

12. Latin America Breast Reconstruction Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2017-2031
    • 12.2.1. Breast Implants
      • 12.2.1.1. Silicone
      • 12.2.1.2. Saline
    • 12.2.2. Tissue Expanders
    • 12.2.3. Acellular Dermal Matrix (ADM)
    • 12.2.4. Others
  • 12.3. Market Value Forecast, by End-user, 2017-2031
    • 12.3.1. Hospitals
    • 12.3.2. Cosmetology Clinics
    • 12.3.3. Ambulatory Surgery Centers
  • 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Product
    • 12.5.2. By End-user
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Breast Reconstruction Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2017-2031
    • 13.2.1. Breast Implants
      • 13.2.1.1. Silicone
      • 13.2.1.2. Saline
    • 13.2.2. Tissue Expanders
    • 13.2.3. Acellular Dermal Matrix (ADM)
    • 13.2.4. Others
  • 13.3. Market Value Forecast, by End-user, 2017-2031
    • 13.3.1. Hospitals
    • 13.3.2. Cosmetology Clinics
    • 13.3.3. Ambulatory Surgery Centers
  • 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Product
    • 13.5.2. By End-user
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (by tier and size of companies)
  • 14.2. Market Share Analysis/Ranking, by Company, 2021
  • 14.3. Company Profiles
    • 14.3.1. AbbVie, Inc.
      • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.1.2. Product Portfolio
      • 14.3.1.3. Financial Overview
      • 14.3.1.4. SWOT Analysis
      • 14.3.1.5. Strategic Overview
    • 14.3.2. Establishment Labs Holdings, Inc.
      • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.2.2. Product Portfolio
      • 14.3.2.3. Financial Overview
      • 14.3.2.4. SWOT Analysis
      • 14.3.2.5. Strategic Overview
    • 14.3.3. GC Aesthetics
      • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.3.2. Product Portfolio
      • 14.3.3.3. Financial Overview
      • 14.3.3.4. SWOT Analysis
      • 14.3.3.5. Strategic Overview
    • 14.3.4. Groupe SEBBIN SAS
      • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.4.2. Product Portfolio
      • 14.3.4.3. Financial Overview
      • 14.3.4.4. SWOT Analysis
      • 14.3.4.5. Strategic Overview
    • 14.3.5. Guangzhou Wanhe Plastic Materials Co., Ltd.
      • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.5.2. Product Portfolio
      • 14.3.5.3. Financial Overview
      • 14.3.5.4. SWOT Analysis
      • 14.3.5.5. Strategic Overview
    • 14.3.6. Integra LifeSciences
      • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.6.2. Product Portfolio
      • 14.3.6.3. Financial Overview
      • 14.3.6.4. SWOT Analysis
      • 14.3.6.5. Strategic Overview
    • 14.3.7. Mentor Worldwide LLC (Johnson & Johnson)
      • 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.7.2. Product Portfolio
      • 14.3.7.3. Financial Overview
      • 14.3.7.4. SWOT Analysis
      • 14.3.7.5. Strategic Overview
    • 14.3.8. POLYTECH Health & Aesthetics GmbH
      • 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.8.2. Product Portfolio
      • 14.3.8.3. Financial Overview
      • 14.3.8.4. SWOT Analysis
      • 14.3.8.5. Strategic Overview
    • 14.3.9. RTI Surgical, Inc.
      • 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.9.2. Product Portfolio
      • 14.3.9.3. Financial Overview
      • 14.3.9.4. SWOT Analysis
      • 14.3.9.5. Strategic Overview
    • 14.3.10. Sientra, Inc.
      • 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.10.2. Product Portfolio
      • 14.3.10.3. Financial Overview
      • 14.3.10.4. SWOT Analysis
      • 14.3.10.5. Strategic Overview
    • 14.3.11. Other prominent players